Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-01 Purchase | 2024-11-05 5:41 pm | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 1,830 | $54.67 | $100,055 | 62,109 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-10 Exercise | 2024-03-12 8:40 pm | N/A 2024-03-10 | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 38,388 | $0 | 205,554 (Direct) | View |
| 2024-03-10 Other | 2024-03-12 8:40 pm | N/A 2026-03-10 | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 22,324 | $0 | 205,554 (Direct) | View |
| 2024-03-10 Option Award | 2024-03-12 8:40 pm | N/A 2028-03-10 | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 101,587 | $0 | 205,554 (Direct) | View |
| 2024-03-10 Tax Withholding | 2024-03-12 8:40 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 13,649 | $53.79 | 205,554 (Direct) | View |
| 2023-07-01 Exercise | 2023-07-05 5:23 pm | N/A 2023-07-01 | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 9,357 | $0 | 47,245 (Direct) | View |
| 2023-07-01 Tax Withholding | 2023-07-05 5:23 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 4,787 | $63.95 | 47,245 (Direct) | View |
| 2023-03-10 Tax Withholding | 2023-03-14 8:18 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 22,395 | $65.71 | 134,283 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-14 8:18 pm | N/A 2024-03-10 | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 38,978 | $0 | 134,283 (Direct) | View |
| 2023-03-10 Option Award | 2023-03-14 8:18 pm | N/A 2027-03-10 | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 58,548 | $0 | 134,283 (Direct) | View |
| 2023-03-10 Other | 2023-03-14 8:18 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 4,800 | $0 | 134,283 (Direct) | View |
| 2022-07-01 Tax Withholding | 2022-07-05 4:28 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 4,786 | $76.84 | 30,649 (Direct) | View |
| 2022-07-01 Exercise | 2022-07-05 4:28 pm | N/A 2023-07-01 | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 9,356 | $0 | 30,649 (Direct) | View |
| 2022-03-10 Exercise | 2022-03-14 9:17 pm | N/A 2024-03-10 | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 9,074 | $0 | 88,515 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 9:17 pm | N/A 2026-03-10 | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 47,655 | $0 | 88,515 (Direct) | View |
| 2022-03-10 Other | 2022-03-14 9:17 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 1,101 | $0 | 88,515 (Direct) | View |
| 2022-03-10 Tax Withholding | 2022-03-14 9:17 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 5,205 | $68.42 | 88,515 (Direct) | View |
| 2021-07-01 Exercise | 2021-07-06 4:38 pm | N/A 2023-07-01 | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 9,356 | $0 | 30,465 (Direct) | View |
| 2021-07-01 Tax Withholding | 2021-07-06 4:38 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 4,786 | $66.56 | 30,465 (Direct) | View |
| 2021-03-10 Exercise | 2021-03-12 6:56 pm | N/A 2024-03-10 | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 4,189 | $0 | 68,682 (Direct) | View |
| 2021-03-10 Option Award | 2021-03-12 6:56 pm | N/A 2025-03-10 | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 48,852 | $0 | 68,682 (Direct) | View |
| 2021-03-10 Other | 2021-03-12 6:56 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 78 | $0 | 68,682 (Direct) | View |
| 2021-03-10 Tax Withholding | 2021-03-12 6:56 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 1,978 | $60.93 | 68,682 (Direct) | View |
| 2020-07-01 Exercise | 2020-07-02 4:56 pm | N/A 2023-07-01 | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 9,356 | $0 | 32,962 (Direct) | View |
| 2020-07-01 Tax Withholding | 2020-07-02 4:56 pm | N/A N/A | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 4,463 | $59.43 | 32,962 (Direct) | View |
| 2020-03-10 Option Award | 2020-03-12 6:15 pm | N/A 2024-03-10 | BRISTOL MYERS SQUIBB CO | BMY | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | 41,898 | $0 | 41,898 (Direct) | View |